Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Emergence of Long-Lived Autoreactive Plasma Cells in the Spleen of Primary Warm Auto-Immune Hemolytic Anemia Patients Treated with Rituximab

Matthieu Mahevas, MD PhD, Marc Michel, MD PhD, Benoit Vingert, Julien Moroch, David Boutboul, Sylvain Audia, MD, PhD, Julie Ripa, Nicolas Cagnard, Karin Tarte, PharmD, PhD, Simon le Gallou, Lan-huong Thai, France Noizat-Pirenne, MDPhD, Bertrand Godeau, MDPhD, Jean-Claude Weill, Claude-Agnès Reynaud

Blood (2014) 124 (21): 569.

https://doi.org/10.1182/blood.V124.21.569.569

Published: 2014

Journal Articles

Causes of Death in Sickle Cell Disease Adult Patients: Old and New Trends

Stéphanie Ngo, MD, Pablo Bartolucci, David Lobo, MD, Armand Mekontso-Dessap, MDPhD, Justine Gellen-Dautremer, MD, France Noizat-Pirenne, MDPhD, Vincent Audard, MDPhD, Bertrand Godeau, MDPhD, Frédéric Galacteros, Anoosha Habibi

Blood (2014) 124 (21): 2715.

https://doi.org/10.1182/blood.V124.21.2715.2715

Published: 2014

Journal Articles

Exposure to Corticoid-Sparing Treatments in Adult Primary Immune Thrombocytopenia before the Chronic Phase in the Era of Thrombopoietin Receptor Agonists in France. a Nationwide Population-Based Study

Guillaume Moulis, MD, Maryse Lapeyre-Mestre, MD PhD, Jean-Louis Montastruc, MD PhD, Bertrand Godeau, MDPhD, Laurent Sailler, MDPhD

Blood (2014) 124 (21): 2178.

https://doi.org/10.1182/blood.V124.21.2178.2178

Published: 2014

Journal Articles

Vaccination Rates in Primary Immune Thrombocytopenia Adult Patients Exposed to Rituximab or Splenectomy. a Nationwide Population-Based Study in France

Guillaume Moulis, MD, Maryse Lapeyre-Mestre, MD PhD, Jean-Louis Montastruc, MD PhD, Bertrand Godeau, MDPhD, Laurent Sailler, MDPhD

Blood (2014) 124 (21): 2180.

https://doi.org/10.1182/blood.V124.21.2180.2180

Published: 2014

Journal Articles

Long-Term Complications after Splenectomy in Adult Chronic Immune Thrombocytopenia with a Minimum Follow up of 10 Years. First Results from a Single-Center Case-Control Study in 140 Patients with Primary ITP

Lan-huong Thai, Matthieu Mahevas, MD PhD, Françoise roudot-Thoraval, Laetitia Languille, Guillaume Dumas, Mehdi Khellaf, Philippe Bierling, MD, Marc Michel, MD PhD, Bertrand Godeau, MDPhD

Blood (2014) 124 (21): 232.

https://doi.org/10.1182/blood.V124.21.232.232

Published: 2014

Journal Articles

99 Episodes of Delayed Hemolysis Post transfusion Reaction among Adult Patients with Sickle Cell Disease; Clinical Presentation, Prognosis, and Treatment

Anoosha Habibi, Constance Guillaud, MD, Armand Mekontso-Dessap, MDPhD, Keyvan Razazi, MD, Justine Gellen- Dautremer, MD, Marc Michel, MD PhD, Bertrand Godeau, MDPhD, Frédéric Galacteros, Pablo Bartolucci, France Noizat-Pirenne, MDPhD

Blood (2014) 124 (21): 4092.

https://doi.org/10.1182/blood.V124.21.4092.4092

Published: 2014

NARROW

Emergence of Long-Lived Autoreactive Plasma Cells in the Spleen of Primary Warm Auto-Immune Hemolytic Anemia Patients Treated with Rituximab

Causes of Death in Sickle Cell Disease Adult Patients: Old and New Trends

Exposure to Corticoid-Sparing Treatments in Adult Primary Immune Thrombocytopenia before the Chronic Phase in the Era of Thrombopoietin Receptor Agonists in France. a Nationwide Population-Based Study

Vaccination Rates in Primary Immune Thrombocytopenia Adult Patients Exposed to Rituximab or Splenectomy. a Nationwide Population-Based Study in France

Long-Term Complications after Splenectomy in Adult Chronic Immune Thrombocytopenia with a Minimum Follow up of 10 Years. First Results from a Single-Center Case-Control Study in 140 Patients with Primary ITP

99 Episodes of Delayed Hemolysis Post transfusion Reaction among Adult Patients with Sickle Cell Disease; Clinical Presentation, Prognosis, and Treatment

Email alerts

ASH Publications

American Society of Hematology

Emergence of Long-Lived Autoreactive Plasma Cells in the Spleen of Primary Warm Auto-Immune Hemolytic Anemia Patients Treated with Rituximab

Causes of Death in Sickle Cell Disease Adult Patients: Old and New Trends

Exposure to Corticoid-Sparing Treatments in Adult Primary Immune Thrombocytopenia before the Chronic Phase in the Era of Thrombopoietin Receptor Agonists in France. a Nationwide Population-Based Study

Vaccination Rates in Primary Immune Thrombocytopenia Adult Patients Exposed to Rituximab or Splenectomy. a Nationwide Population-Based Study in France

Long-Term Complications after Splenectomy in Adult Chronic Immune Thrombocytopenia with a Minimum Follow up of 10 Years. First Results from a Single-Center Case-Control Study in 140 Patients with Primary ITP

99 Episodes of Delayed Hemolysis Post transfusion Reaction among Adult Patients with Sickle Cell Disease; Clinical Presentation, Prognosis, and Treatment

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only